Pfizer names Albert Bourla group president
This article was originally published in Scrip
Pfizer has named Albert Bourla group president of the vaccines, oncology and consumer healthcare business, effective 1 January 2014. He replaces Amy Schulman (www.scripintelligence.com, 17 December 2013), who was due to take up the position when the company began operating under its new three-armed commercial business structure in January 2014. Ms Schulman is stepping down from the company entirely but will remain for a transitional period. Meanwhile, Susan Silbermann has been named president and general manager, of Pfizer's global vaccines business – also effective 1 January 2014.